AMEND news in 2023
-
August 2023: Research Updates
This research round-up offers insights into the latest research and developments concerning Multiple Endocrine Neoplasia type 1 (MEN1). Highlighting key studies, technological advancements like CRISPR, and emerging treatments, the content provides a snapshot of the current challenges and progress in MEN1 research. Compiled by Jason Keller in August 2023, this overview aims to shed light on the ongoing efforts to better understand and address MEN1.
-
Updates from the NIH Clinical Center in Bethesda, Maryland
We have some exciting updates from our colleagues at the National Institutes of Health (NIH) Clinical Center! They're continuing to conduct a special project, the Natural History Study of Parathyroid Disorders, with a significant focus on Multiple Endocrine Neoplasia Type 1 (MEN1). Also learn about some interesting findings the NIH team has observed, made possible through this long-term natural history study.
Updates from the NIH Clinical Center